Telesis Bio (TBIO) Receives a Rating Update From a Top Analyst
Telesis Bio Analyst Ratings
KeyBanc Capital Markets Adjusts Price Target on Codex DNA to $5 From $8, Maintains Overweight Rating
Codex DNA Analyst Ratings
Keybanc Maintains Overweight on Codex DNA, Lowers Price Target to $5
No Data
No Data